|
The Israeli corporate income tax rate was 24% in 2017, 25% in 2016 and 26.5% in 2015.
Effective January 1, 2018 the Israeli corporate income tax rate is 23%.
|
b. |
Significant components of the Company's deferred tax assets and liabilities are as follows:
|
| |
|
December 31,
|
|
| |
|
2016
|
|
|
2017
|
|
|
Deferred tax assets:
|
|
|
|
|
|
|
|
Net operating loss and capital loss carry forward
|
|
$
|
36,284
|
|
|
$
|
40,551
|
|
|
Valuation allowance
|
|
|
(36,284
|
)
|
|
|
(40,551
|
)
|
| |
|
|
|
|
|
|
|
|
|
Net deferred tax asset
|
|
|
-
|
|
|
|
-
|
|
Management currently believes that since the Company has a history of losses it is more likely than not that the deferred tax assets regarding the loss carry-forward will not be realized in the foreseeable future.
|
c. |
Net operating losses carry-forward:
|
The Company has accumulated operating losses for tax purposes as of December 31, 2017 in the amount of approximately $34,988 (denominated in NIS), which may be carried forward and offset against taxable income in the future for an indefinite period.
The Company has accumulated capital losses of approximately $130,014 (denominated in NIS), which may be carried forward and offset against capital gains.
|
d. |
The main reconciling item from the statutory tax rate of the Company to the effective tax rate are valuation allowances provided for deferred tax assets.
|
|
e. |
Tax reports filed by the Company in Israel through the year ended December 31, 2012 are considered final.
|
|
f. |
As of December 31, 2015, 2016 and 2017, the Company did not have any unrecognized tax benefits or uncertain tax positions. |
|